Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
BioVie
BIVI
$11.5M
| $526K | ﹤0.01% |
53,664
+44,636
| +494% | +$714K |
|
3877
Cognition Therapeutics
CGTX
$79.6M
| $522K | ﹤0.01% |
1,239,167
-400
| -0% | -$235 |
|
3878
Senti Biosciences Holdings
SNTI
$10.6M
| $518K | ﹤0.01% |
154,136
+56,669
| +58% | +$221K |
|
|
QIPT
3879
DELISTED
Quipt Home Medical
QIPT
| $517K | ﹤0.01% |
222,092
-26,667
| -11% | -$73.1K |
|
|
MPV
3880
Barings Participation Investors
MPV
$175M
| $515K | ﹤0.01% |
29,200
| – | – |
|
3881
Envoy Medical
COCH
$51.7M
| $513K | ﹤0.01% |
394,961
| – | – |
|
3882
Avantis Emerging Markets Equity ETF
AVEM
$25.4B
| $512K | ﹤0.01% |
8,505
-27
| -0.3% | -$1.62K |
|
3883
Q32 Bio
QTTB
$466M
| $510K | ﹤0.01% |
309,214
-7,358
| -2% | -$19.8K |
|
3884
American Shared Hospital Services
AMS
$9.94M
| $504K | ﹤0.01% |
181,243
| – | – |
|
3885
Live Ventures
LIVE
$29.8M
| $502K | ﹤0.01% |
65,788
| – | – |
|
3886
Vanguard S&P 500 Value ETF
VOOV
$6.59B
| $500K | ﹤0.01% |
2,716
+327
| +14% | +$61.2K |
|
|
FGNX
3887
FG Nexus Inc
FGNX
$41.6M
| $491K | ﹤0.01% |
5,499
+111
| +2% | +$11.4K |
|
|
JCTC
3888
Jewett-Cameron Trading
JCTC
$9.33M
| $491K | ﹤0.01% |
106,937
+18,017
| +20% | +$81.9K |
|
3889
Solitario Resources
XPL
$68.3M
| $491K | ﹤0.01% |
818,029
| – | – |
|
3890
Mobix Labs
MOBX
$25.5M
| $487K | ﹤0.01% |
54,568
+53,021
| +3,427% | +$621K |
|
3891
Gain Therapeutics
GANX
$71.7M
| $487K | ﹤0.01% |
254,990
+77,915
| +44% | +$173K |
|
3892
Mexco Energy
MXC
$17.8M
| $487K | ﹤0.01% |
62,095
| – | – |
|
3893
iShares US Real Estate ETF
IYR
$4.66B
| $486K | ﹤0.01% |
5,079
| – | – |
|
3894
Retractable Technologies
RVP
$19.8M
| $485K | ﹤0.01% |
689,509
| – | – |
|
|
SOHO
3895
DELISTED
Sotherly Hotels
SOHO
| $483K | ﹤0.01% |
689,987
+2,041
| +0.3% | +$1.68K |
|
3896
MultiSensor AI
MSAI
$9.59M
| $483K | ﹤0.01% |
12,974
+4,221
| +48% | +$235K |
|
3897
Spectral AI
MDAI
$49.3M
| $479K | ﹤0.01% |
416,866
+232,125
| +126% | +$429K |
|
|
LAC
3898
Lithium Americas
LAC
$1.01B
| $479K | ﹤0.01% |
177,181
+1,038
| +0.6% | +$3.13K |
|
3899
Vanguard International High Dividend Yield ETF
VYMI
$20.6B
| $476K | ﹤0.01% |
6,457
+540
| +9% | +$38.8K |
|
3900
NextCure
NXTC
$16.8M
| $474K | ﹤0.01% |
82,277
| – | – |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.